What causes delayed periods?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Delayed Periods

Polycystic ovary syndrome (PCOS) is the single most common cause of delayed periods, affecting 4-6% of women in the general population, followed by functional hypothalamic amenorrhea (FHA), hyperprolactinemia, and thyroid dysfunction. 1, 2

Primary Endocrine Causes

Polycystic Ovary Syndrome (PCOS)

  • PCOS accounts for the majority of irregular menstrual cycles and presents with elevated androgens, irregular or absent periods, and polycystic ovarian morphology on ultrasound. 1
  • Laboratory findings typically show an LH:FSH ratio >2, which strongly suggests PCOS. 1
  • The condition is characterized by hyperandrogenic chronic anovulation with accelerated pulsatile GnRH secretion. 2
  • Critical pitfall: Approximately 40-47% of women with FHA have polycystic ovarian morphology (FHA-PCOM), which can be misdiagnosed as PCOS—this distinction is critical because FHA-PCOM requires correction of energy deficit as primary treatment, not PCOS-directed therapy. 1

Functional Hypothalamic Amenorrhea (FHA)

  • FHA accounts for 20-35% of secondary amenorrhea cases and results from functional reduction in GnRH pulsatile secretion. 1, 2
  • Main contributing factors include stress and increased stress sensitivity, vigorous exercise patterns, weight loss and low BMI, psychological disorders, and caloric restriction or energy deficit. 2
  • In athletes, FHA is part of the female athlete triad or Relative Energy Deficiency in Sport (RED-S). 2
  • This condition causes low estrogen levels, not excess estrogen, leading to disruptions in LH pulsatility and decreased estradiol and progesterone. 3

Hyperprolactinemia

  • Accounts for approximately 20% of secondary amenorrhea cases through elevated serum prolactin levels. 1, 2
  • Causes include pituitary adenomas, medications, hypothyroidism, and chronic renal failure. 2
  • Prolactin levels >20 μg/L are considered abnormal, though levels may be mildly raised in patients with epilepsy. 4
  • Pituitary MRI may be indicated if clinical features (galactorrhea) or laboratory results suggest hypothalamic-pituitary axis abnormality. 4

Thyroid Dysfunction

  • Both hypothyroidism and hyperthyroidism cause menstrual irregularities by affecting the hypothalamic-pituitary-ovarian axis. 1, 2
  • Oligomenorrhea (cycles longer than 35 days) is the most common menstrual disturbance in thyroid disorders. 5

Additional Medical Causes

Chronic Liver Disease

  • Advanced liver disease causes menstrual irregularities in >25% of women through altered estrogen metabolism and disruption of the hypothalamic-pituitary axis. 1, 2

Medication-Induced Causes

  • Oral contraceptives frequently induce irregular bleeding patterns, especially during the first three months of use. 1
  • Delayed application or detachment of contraceptive patches for ≥48 hours can cause delayed periods and requires back-up contraception until a patch has been worn for 7 consecutive days. 4

Primary Ovarian Insufficiency

  • Characterized by elevated FSH (>35 IU/L) and LH (>11 IU/L) levels. 4
  • Patients can maintain unpredictable ovarian function and should not be presumed infertile. 6, 7

Diagnostic Approach

Initial Evaluation

  • The first step is always a pregnancy test to exclude pregnancy. 3, 6
  • Obtain menstrual chart for at least 6 months to document cycle patterns: <23 days indicates polymenorrhea, >35 days indicates oligomenorrhea, and no bleeding >6 months indicates amenorrhea. 4

Laboratory Assessment

  • Initial workup should include serum FSH, LH, prolactin, and TSH levels. 6, 7
  • LH, FSH should be measured based on an average of three estimations taken 20 minutes apart between day 3 and 6 of the cycle. 4
  • Progesterone measurement during mid-luteal phase: levels <6 nmol/L indicate anovulation, commonly caused by PCOS, FHA, or hyperprolactinemia. 4

Additional Testing

  • Pelvic ultrasonography is indicated if clinical features or hormonal tests raise concern about ovarian pathology; transvaginal ultrasound is more sensitive than transabdominal. 4
  • Androgen profile should be obtained for suspected PCOS. 7
  • Karyotyping may be needed for primary amenorrhea or suspected chromosomal abnormalities. 7

Clinical Red Flags and Screening

Assess for Associated Conditions

  • Evaluate for eating disorders, excessive exercise, and psychological stressors in suspected FHA, as these patients are at risk for decreased bone density. 6, 7
  • Screen for obesity (BMI >25) and truncal obesity (waist/hip ratio >0.9), assessing menstrual regularity in cases of cycle disturbance. 4
  • Look for hirsutism (male escutcheon pattern), which may indicate hyperandrogenism requiring investigation. 4
  • Check for galactorrhea (crusting on nipples, expression of breast milk in non-lactating women), which warrants prolactin measurement and exclusion of hypothyroidism. 4

Long-term Health Implications

  • Decreased bone mineral density and increased risk of osteoporosis are major complications of irregular menses, particularly in hypoestrogenic states. 1, 2
  • Women with menstrual disorders have higher risk of developing hypertension and other cardiometabolic risk factors. 1
  • PCOS patients are at risk for glucose intolerance, dyslipidemia, and metabolic syndrome. 6

References

Guideline

Causes and Consequences of Irregular Menstruation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Causes and Consequences of Irregular Menses

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Estrogen Deficiency and Secondary Amenorrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The Menstrual Disturbances in Endocrine Disorders: A Narrative Review.

International journal of endocrinology and metabolism, 2020

Research

Amenorrhea: an approach to diagnosis and management.

American family physician, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.